A new trading day began on Tuesday, with Bioline Rx Ltd ADR (NASDAQ: BLRX) stock price up 15.90% from the previous day of trading, before settling in for the closing price of $0.46. BLRX’s price has ranged from $0.39 to $1.89 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 88.83%. With a float of $79.55 million, this company’s outstanding shares have now reached $79.99 million.
The firm has a total of 38 workers. Let’s measure their productivity. In terms of profitability, gross margin is 63.25%, operating margin of -204.22%, and the pretax margin is -176.67%.
Bioline Rx Ltd ADR (BLRX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Bioline Rx Ltd ADR is 0.56%, while institutional ownership is 4.07%.
Bioline Rx Ltd ADR (BLRX) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.3 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 88.83% per share during the next fiscal year.
Bioline Rx Ltd ADR (NASDAQ: BLRX) Trading Performance Indicators
Here are Bioline Rx Ltd ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.45, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.16 in one year’s time.
Technical Analysis of Bioline Rx Ltd ADR (BLRX)
Analysing the last 5-days average volume posted by the [Bioline Rx Ltd ADR, BLRX], we can find that recorded value of 0.53 million was better than the volume posted last year of 0.35 million. As of the previous 9 days, the stock’s Stochastic %D was 78.84%. Additionally, its Average True Range was 0.04.
During the past 100 days, Bioline Rx Ltd ADR’s (BLRX) raw stochastic average was set at 29.28%, which indicates a significant decrease from 91.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.11% in the past 14 days, which was lower than the 81.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5052, while its 200-day Moving Average is $0.7341. Now, the first resistance to watch is $0.5676. This is followed by the second major resistance level at $0.5989. The third major resistance level sits at $0.6477. If the price goes on to break the first support level at $0.4875, it is likely to go to the next support level at $0.4387. Now, if the price goes above the second support level, the third support stands at $0.4074.
Bioline Rx Ltd ADR (NASDAQ: BLRX) Key Stats
With a market capitalization of 42.91 million, the company has a total of 79,939K Shares Outstanding. Currently, annual sales are 4,800 K while annual income is -60,610 K. The company’s previous quarter sales were 5,390 K while its latest quarter income was 480 K.
